Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Topical WS-0101 in Healthy Adult Subjects: a First-in-Human Clinical Trial

NCT06857799 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06857799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06857799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Topical WS-0101 in Healthy Adult Subjects: a First-in-Human Clinical Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 1
Overall status
Completed
Start date
May 13, 2024
Completion date
September 23, 2024
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult subjects